10-132810960-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001200049.3(CFAP46):c.7573G>A(p.Glu2525Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000855 in 1,601,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001200049.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP46 | NM_001200049.3 | c.7573G>A | p.Glu2525Lys | missense_variant | 56/58 | ENST00000368586.10 | NP_001186978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP46 | ENST00000368586.10 | c.7573G>A | p.Glu2525Lys | missense_variant | 56/58 | 5 | NM_001200049.3 | ENSP00000357575.4 | ||
CFAP46 | ENST00000639072.2 | c.7573G>A | p.Glu2525Lys | missense_variant | 56/59 | 5 | ENSP00000491877.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152262Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000150 AC: 34AN: 227004Hom.: 0 AF XY: 0.000154 AC XY: 19AN XY: 123050
GnomAD4 exome AF: 0.0000925 AC: 134AN: 1449064Hom.: 0 Cov.: 31 AF XY: 0.000107 AC XY: 77AN XY: 719652
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152380Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.2509G>A (p.E837K) alteration is located in exon 21 (coding exon 21) of the CFAP46 gene. This alteration results from a G to A substitution at nucleotide position 2509, causing the glutamic acid (E) at amino acid position 837 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at